| LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression. | LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression.
Wu G, Dong Z, Dong Y, Chen Y, Zhu H, Ding D, Cui Y, Wang Y, Xu Y, Chen H., Free PMC Article | 06/3/2024 |
| Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-kappaB Pathways. | Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways.
Selimovic D, Kharouf N, Carrouel F, Hassan SY, Flanagan TW, Hassan SL, Megahed M, Haikel Y, Santourlidis S, Hassan M., Free PMC Article | 03/30/2023 |
| Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer. | Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer.
Wang C, Chen Y, Xinpeng Y, Xu R, Song J, Ruze R, Xu Q, Zhao Y., Free PMC Article | 08/20/2022 |
| Circ_0003221 Downregulation Restrains Cervical Cancer Cell Growth, Metastasis and Angiogenesis by Governing the miR-139-3p/S100A14 Pathway. | Circ_0003221 Downregulation Restrains Cervical Cancer Cell Growth, Metastasis and Angiogenesis by Governing the miR-139-3p/S100A14 Pathway.
Chi X, Gu X, Chen S, Shen X. | 05/28/2022 |
| S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. | S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H, Gao W, Li X, Yu L, Luo D, Liu Y, Yu X. | 11/22/2021 |
| S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway. | S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway.
Jiang S, Zhu Y, Chen Z, Huang Z, Liu B, Xu Y, Li Z, Lin Z, Li M. | 11/6/2021 |
| Loss of S100A14 expression at the tumor-invading front correlates with poor differentiation and worse prognosis in oral squamous cell carcinoma. | Loss of S100A14 expression at the tumor-invading front correlates with poor differentiation and worse prognosis in oral squamous cell carcinoma.
Pandey S, Osman TA, Sharma S, Vallenari EM, Shahdadfar A, Pun CB, Gautam DK, Uhlin-Hansen L, Rikardsen O, Johannessen AC, Costea DE, Sapkota D. | 08/28/2021 |
| S100A14 serum level and its correlation with prognostic factors in breast cancer. | S100A14 serum level and its correlation with prognostic factors in breast cancer.
Al-Ashkar N, Zetoune AB. | 08/14/2021 |
| A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis. | A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X, Wang M, Gong T, Lei X, Hu T, Tian M, Ding F, Ma F, Chen H, Liu Z., Free PMC Article | 08/7/2021 |
| S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1. | S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
Meng DF, Sun R, Liu GY, Peng LX, Zheng LS, Xie P, Lin ST, Mei Y, Qiang YY, Li CZ, Xu L, Peng XS, Hu H, Lang YH, Liu ZJ, Wang MD, Guo LL, Xie DH, Shu DT, Li HF, Luo FF, Niu XT, Huang BJ, Qian CN. | 12/5/2020 |
| Low S100A14 expression is associated with Colorectal Cancer. | A Clinicopathological Analysis of S100A14 Expression in Colorectal Cancer.
Diamantopoulou A, Mantas D, Kostakis ID, Agrogiannis G, Garoufalia Z, Kavantzas N, Kouraklis G., Free PMC Article | 06/13/2020 |
| S100A14 increases the motility of lung adenocarcinoma cells, and might be a diagnostic and prognostic serum biomarker and potential therapeutic target for lung adenocarcinoma. | Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Ding F, Wang D, Li XK, Yang L, Liu HY, Cui W, Liu ZH, Che YQ., Free PMC Article | 02/16/2019 |
| S100A14 is expressed in a subset of lung adenocarcinoma, and its expression is related to certain clinicopathological parameters. Furthermore, S100A14 expression was strongly correlated with migration and invasion in lung adenocarcinoma cells. | Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.
Katono K, Sato Y, Kobayashi M, Saito K, Nagashio R, Ryuge S, Igawa S, Nakashima H, Shiomi K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Masuda N. | 10/13/2018 |
| Increased S100A15 expression and decreased DNA methylation of its gene promoter region were associated with high metastasis potential and poor outcome in lung adenocarcinoma. | Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC, Lin MC, Hsiao CC, Zheng YX, Chen KD, Sung MT, Chen CJ, Wang TY, Lin YY, Chang HC, Chen YM, Chang JC., Free PMC Article | 04/14/2018 |
| results indicate that S100A14 may have a role in the induction of differentiation and inhibition of cell metastasis in gastric cancer. | Calcium-binding protein S100A14 induces differentiation and suppresses metastasis in gastric cancer.
Zhu M, Wang H, Cui J, Li W, An G, Pan Y, Zhang Q, Xing R, Lu Y., Free PMC Article | 04/7/2018 |
| We identified a two-gene signature including KCNN4 and S100A14 which was related to recurrence in optimally debulked serous ovarian carcinoma patients | KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.
Zhao H, Guo E, Hu T, Sun Q, Wu J, Lin X, Luo D, Sun C, Wang C, Zhou B, Li N, Xia M, Lu H, Meng L, Xu X, Hu J, Ma D, Chen G, Zhu T., Free PMC Article | 01/20/2018 |
| Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion | Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M, Ichikawa-Tomikawa N, Shishito N, Nishiura K, Miura T, Hozumi A, Chiba H, Yoshida S, Ohtake T, Sugino T., Free PMC Article | 01/2/2016 |
| The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts | The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts.
Gauglitz GG, Bureik D, Zwicker S, Ruzicka T, Wolf R. | 12/5/2015 |
| S100A14 is expressed in epithelial-like, but not in mesenchymal-like, triple-negative breast cancer cells in vitro. | S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.
Ehmsen S, Hansen LT, Bak M, Brasch-Andersen C, Ditzel HJ, Leth-Larsen R. | 10/31/2015 |
| Data show that the genetic variant 425G>A on the 5'-UTR of calcium-binding protein S100A14 was associated with reduced S100A14 expression in gastric cancer (GC) cells. | Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer.
Zhang Q, Zhu M, Cheng W, Xing R, Li W, Zhao M, Xu L, Li E, Luo G, Lu Y. | 06/20/2015 |
| Data indicate that S100A14 has a crucial role in EOC progression, and its overexpression is associated with poor prognosis. | The role of S100A14 in epithelial ovarian tumors.
Cho H, Shin HY, Kim S, Kim JS, Chung JY, Chung EJ, Chun KH, Hewitt SM, Kim JH., Free PMC Article | 04/25/2015 |
| Data demonstrate that S100A14 is transcriptionally regulated by JunB and involved in esophageal squamous cell carcinoma cell differentiation. | S100A14: novel modulator of terminal differentiation in esophageal cancer.
Chen H, Ma J, Sunkel B, Luo A, Ding F, Li Y, He H, Zhang S, Xu C, Jin Q, Wang Q, Liu Z. | 08/9/2014 |
| S100A14 interacts with S100A16 and regulates its expression in human cancer cells. | S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
Sapkota D, Costea DE, Ibrahim SO, Johannessen AC, Bruland O., Free PMC Article | 07/19/2014 |
| Data show that S100A14 and HER2 are colocalized in plasma membrane of breast cancer tissue cells and breast cancer cell lines. | S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.
Xu C, Chen H, Wang X, Gao J, Che Y, Li Y, Ding F, Luo A, Zhang S, Liu Z., Free PMC Article | 04/12/2014 |
| High S100A14 expression is associated with metastasis of hepatocellular carcinoma. | S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
Zhao FT, Jia ZS, Yang Q, Song L, Jiang XJ. | 02/22/2014 |